Trial Information
Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa
Descriptive pharmacoepidemiological study of patients treated with Iressa
Inclusion Criteria:
- Patients treated with Iressa
Exclusion Criteria:
- Patient included in a therapeutic trial comprising protocol use of Iressa
- Patient included in a therapeutic trial (Huriet-Serusclat Act)
- Patient refusing to participate in the study
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
The Overall survival
Outcome Time Frame:
24 months
Safety Issue:
Yes
Principal Investigator
Thierry BOUILLET, Dr
Investigator Role:
Principal Investigator
Investigator Affiliation:
Bobigny
Authority:
France: French Data Protection Authority
Study ID:
NIS-OFR-IRE-2011/1
NCT ID:
NCT01448187
Start Date:
January 2012
Completion Date:
January 2015
Related Keywords:
- Lung Cancer
- Lung cancer, France
- Lung Neoplasms